Business
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
Agreement with St. Vincent Health marks HeartSciences’ transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College of Cardiology Annual Scientific SessionSouthlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration o
About this update from Heartsciences Inc.
[{"type":"image","alt":"HeartSciences Inc.","displaySize":"","headline":null,"caption":"HeartSciences Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":271,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Nd6jGsxxZHYUHrltY16kpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkw/https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d","width":271,"height":58}},"lazy":false},{"type":"text","content":"Agreement with St. Vincent Health marks HeartSciences’ transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College of Cardiology Annual Scientific Session","length":240,"tagName":"p"},{"type":"text","content":"Southlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that it has signed a commercial agreement with St. Vincent Health, a Critical Access Hospital serving Lake County, Colorado, to deploy the MyoVista Insights™ platform.","length":477,"tagName":"p"},{"type":"text","content":"The agreement marks an important commercial milestone for HeartSciences, representing the Company’s first mainstream revenue-generating deployment of MyoVista Insights, building on previously announced reference and early adopter installations. MyoVista Insights is offered under a SaaS-based recurring revenue model, and HeartSciences is in active discussions with additional healthcare organizations and expects further commercial agreements over the coming quarters.","length":469,"tagName":"p"},{"type":"text","content":"MyoVista Insights is a cloud-native, SaaS-based ECG management platform purpose-built to improve workflow efficiency, provide enterprise-grade EHR interoperability, and enable the deployment of cleared AI-ECG algorithms directly into routine clinical workflows. It is device-agnostic and designed to scale across healthcare facilities of all sizes.","length":348,"tagName":"p"},{"type":"text","content":"Andrew Simpson, Chief Executive Officer of HeartSciences, said, “This agreement represents an impo...